AU2001269698A1 - Heterocycle carboxamides as antiviral agents - Google Patents

Heterocycle carboxamides as antiviral agents

Info

Publication number
AU2001269698A1
AU2001269698A1 AU2001269698A AU6969801A AU2001269698A1 AU 2001269698 A1 AU2001269698 A1 AU 2001269698A1 AU 2001269698 A AU2001269698 A AU 2001269698A AU 6969801 A AU6969801 A AU 6969801A AU 2001269698 A1 AU2001269698 A1 AU 2001269698A1
Authority
AU
Australia
Prior art keywords
antiviral agents
carboxamides
heterocycle
heterocycle carboxamides
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269698A
Other languages
English (en)
Inventor
Scott D. Larsen
Mark E. Schnute
Valerie A Vaillancourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2001269698A1 publication Critical patent/AU2001269698A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
AU2001269698A 2000-07-12 2001-06-25 Heterocycle carboxamides as antiviral agents Abandoned AU2001269698A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21755600P 2000-07-12 2000-07-12
US60/217,556 2000-07-12
PCT/US2001/016492 WO2002004443A2 (fr) 2000-07-12 2001-06-25 Carboxamides heterocycliques utilises comme agents antiviraux

Publications (1)

Publication Number Publication Date
AU2001269698A1 true AU2001269698A1 (en) 2002-01-21

Family

ID=22811560

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001269698A Abandoned AU2001269698A1 (en) 2000-07-12 2001-06-25 Heterocycle carboxamides as antiviral agents
AU2001269697A Abandoned AU2001269697A1 (en) 2000-07-12 2001-06-25 Heterocycle carboxamides as antiviral agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001269697A Abandoned AU2001269697A1 (en) 2000-07-12 2001-06-25 Heterocycle carboxamides as antiviral agents

Country Status (7)

Country Link
US (2) US6730682B2 (fr)
EP (2) EP1363907A2 (fr)
JP (2) JP2004502758A (fr)
AR (2) AR030244A1 (fr)
AU (2) AU2001269698A1 (fr)
PE (2) PE20020143A1 (fr)
WO (2) WO2002004422A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031028A3 (cs) 2000-10-12 2003-08-13 Merck & Co., Inc. Aza- a polyazanaftalenylkarboxamidy
DE60128936T2 (de) 2000-10-12 2008-04-10 Merck & Co, Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
WO2002055079A2 (fr) 2000-10-12 2002-07-18 Merck & Co Inc Aza- et polyaza-naphthalenyl carboxamides convenant comme inhibiteurs de l'integrase du vih
EP2033952B1 (fr) 2001-03-01 2012-08-29 Shionogi&Co., Ltd. Composés d'hétéroaryle contenant de l'azote exerçant un effet inhibiteur sur l'intégrase du VIH
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
ES2291642T3 (es) 2002-01-17 2008-03-01 MERCK & CO., INC. Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih.
JP4494020B2 (ja) 2002-03-15 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド
BRPI0306214B1 (pt) * 2002-11-20 2017-08-08 Japan Tobacco Inc. 4-oxoquinoline compound and use of this as a hiv integrase inhibitor
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
DE10320780A1 (de) * 2003-05-09 2005-01-20 Bayer Healthcare Ag Heterocyclyl-substituierte Dihydrochinazoline
WO2004106334A2 (fr) * 2003-05-28 2004-12-09 Pfizer Products Inc. Procede de preparation de 1,5-naphtyridine-3-carboxyamides par amidation directe d'esters
DE10352499A1 (de) * 2003-11-11 2005-06-09 Bayer Healthcare Ag Substituierte Dihydrochinazoline II
DE102004022672A1 (de) * 2004-05-07 2005-11-24 Bayer Healthcare Ag Substituierte Azachinazoline
WO2005113509A1 (fr) * 2004-05-20 2005-12-01 Japan Tobacco Inc. Nouveau composé 4-oxoquinoline et utilisation de celui-ci comme inhibiteur d'intégrase de vih
GB0428475D0 (en) * 2004-12-30 2005-02-02 4 Aza Bioscience Nv Pyrido(3,2-D)pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders
CN101166730A (zh) 2005-03-01 2008-04-23 惠氏公司 噌啉化合物及其作为肝x受体调节剂的用途
DE102005027517A1 (de) * 2005-06-15 2006-12-21 Bayer Healthcare Ag Verfahren zur Herstellung von Dihydrochinazolinen
AU2006261607A1 (en) * 2005-06-24 2006-12-28 Gilead Sciences, Inc. Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis C.
IN2014CN00613A (fr) * 2006-03-06 2015-08-21 Japan Tobacco Inc
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections
US8143394B2 (en) * 2006-12-26 2012-03-27 Gilead Sciences, Inc. Pyrido(3,2-d)pyrimidines useful for treating viral infections
TW200840584A (en) * 2006-12-26 2008-10-16 Gilead Sciences Inc Pyrido(3,2-d)pyrimidines useful for treating viral infections
US8637531B2 (en) * 2006-12-26 2014-01-28 Gilead Sciences, Inc. Pyrido(3,2-d)pyridmidines useful for treating viral infections
US8536187B2 (en) * 2008-07-03 2013-09-17 Gilead Sciences, Inc. 2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections
EP3317277B1 (fr) 2015-07-01 2021-01-20 Crinetics Pharmaceuticals, Inc. Modulateurs de la somatostatine et leurs utilisations
WO2017058242A1 (fr) * 2015-10-02 2017-04-06 United Technologies Corporation Cellule électronique de puissance universelle pour production distribuée
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
CN112890578A (zh) 2017-08-09 2021-06-04 沙克忍者运营有限责任公司 烹饪系统
KR20230170813A (ko) 2018-09-12 2023-12-19 노파르티스 아게 항바이러스 피리도피라진디온 화합물
US11667613B2 (en) 2019-09-26 2023-06-06 Novartis Ag Antiviral pyrazolopyridinone compounds
US20230077499A1 (en) * 2019-12-20 2023-03-16 Merck Sharp & Dohme Llc Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses
CA3235718A1 (fr) 2021-10-28 2023-05-04 Insilico Medicine Ip Limited Inhibiteurs de la proteine contenant un domaine prolyl hydroxylase (phd) et leurs utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0733729A (ja) 1993-07-26 1995-02-03 Kirin Brewery Co Ltd Ｎ−シアノ−ｎ′−置換−アリールカルボキシイミダミド化合物の製造法
JPH08301849A (ja) 1995-05-01 1996-11-19 Takeda Chem Ind Ltd ヘテロ環化合物およびその製造法
ATE239477T1 (de) 1995-08-02 2003-05-15 Darwin Discovery Ltd Chinolone und deren therapeutische verwendung
CA2225555A1 (fr) 1995-08-02 1997-02-13 Chiroscience Limited Quinolones et leur utilisation therapeutique
US5945431A (en) 1996-03-15 1999-08-31 Biochem Therapeutics Incorporated Cytomegalovirus inhibiting compounds
GB9605437D0 (en) 1996-03-15 1996-05-15 Iaf Biochem Int Cytomegalovirus inhibiting compounds
AU4172197A (en) 1996-09-10 1998-04-02 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
US5932618A (en) 1996-11-04 1999-08-03 Signal Pharmaceuticals, Inc. Anti-viral agents and methods relating to the use thereof
WO1999010347A1 (fr) 1997-08-25 1999-03-04 Neurogen Corporation 4-oxo-naphtyridine-3-carboxamides substitues comme ligands de recepteur de gaba du cerveau
NZ505362A (en) 1997-12-22 2004-12-24 Upjohn Co 4-hydroxyquinoline-3-carboxamides and -hydrazides useful as antiviral agents
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
JP2000256323A (ja) 1999-01-08 2000-09-19 Japan Tobacco Inc ２−オキソキノリン化合物及びその医薬用途
US6248736B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
DK1159279T3 (da) 1999-03-09 2003-02-17 Upjohn Co 4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler

Also Published As

Publication number Publication date
WO2002004443A2 (fr) 2002-01-17
PE20020143A1 (es) 2002-02-15
US20040180910A1 (en) 2004-09-16
EP1299360A2 (fr) 2003-04-09
WO2002004422A2 (fr) 2002-01-17
WO2002004443A3 (fr) 2003-09-12
EP1363907A2 (fr) 2003-11-26
AR030244A1 (es) 2003-08-13
JP2004502758A (ja) 2004-01-29
JP2004502769A (ja) 2004-01-29
AU2001269697A1 (en) 2002-01-21
AR030243A1 (es) 2003-08-13
US20020019397A1 (en) 2002-02-14
PE20020256A1 (es) 2002-03-23
US6730682B2 (en) 2004-05-04
WO2002004422A3 (fr) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001269700A1 (en) Heterocycle carboxamides as antiviral agents
AU2001269698A1 (en) Heterocycle carboxamides as antiviral agents
AU2001269699A1 (en) Heterocycle carboxamides as antiviral agents
AU2002221344A1 (en) Antiviral agents
AU2001280796A1 (en) Electrowetting-driven micropumping
AUPQ713000A0 (en) Kneepad
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001230537A1 (en) Pyridoxazine derivatives
EP1151667A3 (fr) Agent d'activation de plantes
AU2001252971A1 (en) Tiller
AU4890301A (en) 6-methylnicotinamide derivatives as antiviral agents
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001236065A1 (en) Antiviral compounds
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU2001267135A1 (en) Medicaments
AU2002224048A1 (en) Manipulator
IL154920A0 (en) Delta 1-pyrrollines for use as pesticides
AU2002219846A1 (en) Novel use
AU2001295326A1 (en) Chloramines as antiviral agents
AU6286101A (en) New use
AU2001274683A1 (en) Contrast agents